To investigate the role of NUCB2/Nesfatin-1 in breast cancer, we used shRNA to knock down NUCB2 expression in BT-549 and MDA-MB-231 cells, which express NUCB2/Nesfatin-1 at high levels (Fig. 1D, E). The gene discussed is NUCB2; the disease is breast cancer.